首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Photoaffinity labeling of the beta-adrenergic receptor from cultured lymphoma cells with 125Iiodoazidobenzylpindolol: loss of the label with desensitization.
【2h】

Photoaffinity labeling of the beta-adrenergic receptor from cultured lymphoma cells with 125Iiodoazidobenzylpindolol: loss of the label with desensitization.

机译:用125I碘叠氮基苄基吲哚酚对培养的淋巴瘤细胞中的β-肾上腺素受体进行光亲和性标记:脱敏导致标记丢失。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The beta-adrenergic antagonist [125I]iodoazidobenzylpindolol ( [125I]IABP) specifically photolabeled two polypeptides in membrane preparations from wild-type (WT) and coupling protein-deficient cyc- cultured lymphoma cells. The molecular weights of the two polypeptides determined by sodium dodecyl sulfate/polyacrylamide gel electrophoresis were 65,000 and 55,000. They were labeled in a ratio of approximately 1:1. Pretreatment of intact WT or cyc- cells with 1.0 microM epinephrine for 15 min (desensitization) resulted in a greater loss of the 55,000 Mr polypeptide (40-60%) relative to the 65,000 Mr peptide (10-30% loss). An 18- to 24-hr pretreatment of WT cells with terbutaline (down-regulation) led to a greater than 90% reduction of the photolabeling of both polypeptides, whereas a similar pretreatment of cyc- cells resulted in no further loss of labeled receptor than that observed after only a 15-min pretreatment with epinephrine. There was no indication of a change in the electrophoretic mobility of the [125I]IABP-labeled receptors after either short- or long-term agonist pretreatment. These data provide direct evidence for heterogeneity of the beta-adrenergic receptor in lymphoma cells. The differential loss of the [125I]IABP labeling in the two polypeptides suggests a functional heterogeneity as well.
机译:β-肾上腺素能拮抗剂[125I]碘叠氮基苄基吲哚醇([125I] IABP)在野生型(WT)和偶联蛋白缺陷的cyc培养的淋巴瘤细胞的膜制剂中特异性标记了两种多肽。通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳测定的两个多肽的分子量为65,000和55,000。它们以大约1:1的比例标记。相对于65,000 Mr肽,用1.0 microM肾上腺素预处理完整的WT或cyc-细胞15分钟(脱敏)导致55,000 Mr多肽(40-60%)的损失更大(损失10-30%)。用特布他林对WT细胞进行18至24小时的预处理(下调)可导致两种多肽的光标记降低90%以上,而对cyc-细胞进行的类似预处理不会导致比标记的受体损失更多仅用肾上腺素预处理15分钟后观察到的结果。短期或长期激动剂预处理后,没有迹象表明[125I] IABP标记的受体的电泳迁移率发生变化。这些数据提供了淋巴瘤细胞中β-肾上腺素受体异质性的直接证据。两种多肽中[125I] IABP标记的差异丢失也暗示了功能异质性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号